by Elena Iemma | Dec 9, 2024 | News
PROVIDENCE, R.I., Dec. 6, 2024 — EpiVax, Inc., a leader in preclinical immunogenicity risk assessment for biologic and peptide therapeutics, celebrates a productive 2024 marked by scientific innovation, service diversification, and corporate growth....
by Elena Iemma | May 12, 2024 | Blog
The Time is Now for Tregs! I spoke at a conference on Treg-directed therapies this week and wow! Things are happening in Tregitopia! There were lots of fancy companies (e.g. Jeff Bluestone’s Sonoma featuring products named after grapes) aiming to use CAR-T-like...
